D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+4.33%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$82B
AUM Growth
+$3.66B
Cap. Flow
-$9B
Cap. Flow %
-10.97%
Top 10 Hldgs %
11.9%
Holding
4,466
New
785
Increased
1,428
Reduced
1,270
Closed
449

Sector Composition

1 Technology 19.98%
2 Consumer Discretionary 13.5%
3 Financials 10.53%
4 Healthcare 10.18%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MBIO icon
2926
Mustang Bio
MBIO
$11.4M
$509K ﹤0.01%
409
+256
+167% +$319K
AXTI icon
2927
AXT Inc
AXTI
$169M
$507K ﹤0.01%
+57,583
New +$507K
CRBP icon
2928
Corbus Pharmaceuticals
CRBP
$116M
$505K ﹤0.01%
27,317
+4,693
+21% +$86.8K
POR icon
2929
Portland General Electric
POR
$4.66B
$505K ﹤0.01%
+9,544
New +$505K
ODT
2930
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$505K ﹤0.01%
374,195
+140,855
+60% +$190K
PVLA
2931
Palvella Therapeutics, Inc. Common Stock
PVLA
$629M
$504K ﹤0.01%
+1,667
New +$504K
GACQW
2932
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
$504K ﹤0.01%
840,000
+560,000
+200% +$336K
USX
2933
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$502K ﹤0.01%
85,588
+65,488
+326% +$384K
DB icon
2934
Deutsche Bank
DB
$71.6B
$500K ﹤0.01%
40,026
-4,900
-11% -$61.2K
ICVX
2935
DELISTED
Icosavax, Inc. Common Stock
ICVX
$498K ﹤0.01%
21,773
+2,266
+12% +$51.8K
PNTG icon
2936
Pennant Group
PNTG
$884M
$497K ﹤0.01%
21,517
+13,707
+176% +$317K
RNR icon
2937
RenaissanceRe
RNR
$11.6B
$497K ﹤0.01%
2,935
-4,069
-58% -$689K
SVM
2938
Silvercorp Metals
SVM
$1.15B
$497K ﹤0.01%
132,900
+47,400
+55% +$177K
GLUE icon
2939
Monte Rosa Therapeutics
GLUE
$297M
$492K ﹤0.01%
24,085
-23,039
-49% -$471K
RVMD icon
2940
Revolution Medicines
RVMD
$8.7B
$492K ﹤0.01%
+19,541
New +$492K
EXTN
2941
DELISTED
Exterran Corporation
EXTN
$491K ﹤0.01%
164,869
-69,878
-30% -$208K
ASZ.WS
2942
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$489K ﹤0.01%
499,999
LZB icon
2943
La-Z-Boy
LZB
$1.39B
$488K ﹤0.01%
13,442
-19,617
-59% -$712K
PFS icon
2944
Provident Financial Services
PFS
$2.59B
$488K ﹤0.01%
+20,150
New +$488K
WGSWW
2945
GeneDx Holdings Corp. Warrant
WGSWW
$2.5M
$488K ﹤0.01%
498,333
BLDP
2946
Ballard Power Systems
BLDP
$622M
$486K ﹤0.01%
38,726
+9,502
+33% +$119K
PLOW icon
2947
Douglas Dynamics
PLOW
$752M
$486K ﹤0.01%
12,454
-21,519
-63% -$840K
ISO
2948
DELISTED
IsoPlexis Corporation Common Stock
ISO
$486K ﹤0.01%
+52,841
New +$486K
STBA icon
2949
S&T Bancorp
STBA
$1.5B
$485K ﹤0.01%
15,378
+493
+3% +$15.5K
LOGI icon
2950
Logitech
LOGI
$16B
$484K ﹤0.01%
5,871
-2,532
-30% -$209K